NBLY.F Stock Overview
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Neighbourly Pharmacy Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$13.71 |
| 52 Week High | CA$13.71 |
| 52 Week Low | CA$12.94 |
| Beta | 0.29 |
| 1 Month Change | 5.95% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| NBLY.F | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | 0% | 0.7% | 1.2% |
| 1Y | n/a | 28.4% | 20.8% |
Return vs Industry: Insufficient data to determine how NBLY.F performed against the US Consumer Retailing industry.
Return vs Market: Insufficient data to determine how NBLY.F performed against the US Market.
Price Volatility
| NBLY.F volatility | |
|---|---|
| NBLY.F Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 5.0% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NBLY.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NBLY.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 3,648 | Skip Bourdo | neighbourlypharmacy.ca |
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy’s RX, and Drug Trading.
Neighbourly Pharmacy Inc. Fundamentals Summary
| NBLY.F fundamental statistics | |
|---|---|
| Market cap | US$619.59m |
| Earnings (TTM) | -US$24.11m |
| Revenue (TTM) | US$644.81m |
1.0x
P/S Ratio-25.6x
P/E RatioIs NBLY.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NBLY.F income statement (TTM) | |
|---|---|
| Revenue | CA$874.61m |
| Cost of Revenue | CA$527.56m |
| Gross Profit | CA$347.05m |
| Other Expenses | CA$379.76m |
| Earnings | -CA$32.70m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 39.68% |
| Net Profit Margin | -3.74% |
| Debt/Equity Ratio | 44.5% |
How did NBLY.F perform over the long term?
See historical performance and comparison